About Hospital del Mar; Servicio de Oncologia
El Hospital del Mar, es un centro sanitario general moderno, universitario, activo, investigador, que atiende patologías de complejidad media y alta situado en el Paseo Marítimo de Barcelona. Fue inaugurado en el año 1905, siendo uno de los hospitales más importantes de Barcelona.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
37
EMD Serono Research & Development Institute, Inc.
3
Genentech, Inc.
2
Clovis Oncology, Inc.
1
Gilead Sciences
1
Ipsen
1
Clinical Trials at Hospital del Mar; Servicio de Oncologia
During the past decade, Hospital del Mar; Servicio de Oncologia conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 17 clinical trials were completed, i.e. on
average, 63% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 9 clinical trials were completed. i.e. 90%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
2008-10-16
2029-09-20
Recruiting
720
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
2010-07-31
2016-09-16
Completed
1,095
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian Cancer
2011-06-14
2016-06-03
Completed
87
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer
2011-12-06
2017-10-31
Completed
30
A Study of RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell Origin
2011-12-01
2016-02-01
Completed
145
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer
2012-02-17
2019-11-14
Completed
258
A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers
2012-04-12
2016-10-28
Completed
208
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital del Mar; Servicio de Oncologia" #1 sponsor was "Hoffmann-La Roche" with 37 trials, followed by "EMD Serono Research & Development Institute, Inc." with 3 trials
sponsored, "Genentech, Inc." with 2 trials sponsored, "Clovis Oncology, Inc." with 1 trials sponsored and "Gilead Sciences"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital del Mar; Servicio de Oncologia"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Foundation Medicine" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Hospital del Mar; Servicio de Oncologia
According to Clinical.Site data, the most researched conditions in "Hospital del Mar; Servicio de Oncologia" are
"Breast Cancer" (9 trials), "Non-small Cell Lung Cancer" (4 trials), "Solid Tumors" (4 trials), "Neoplasms" (3 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "Hospital del Mar; Servicio de Oncologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital del Mar; Servicio de Oncologia
Most popular intervention types in "Hospital del Mar; Servicio de Oncologia" are "Drug" (44 trials), "Radiation" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (10 trials), "Placebo" (9 trials), "Pertuzumab" (8 trials), "Trastuzumab" (8 trials) and "Paclitaxel" (7 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital del Mar; Servicio de Oncologia
The vast majority of trials in "Hospital del Mar; Servicio de Oncologia" are
43 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Hospital del Mar; Servicio de Oncologia
Currently, there are NaN active trials in "Hospital del Mar; Servicio de Oncologia".
undefined are not yet recruiting,
12 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 24 completed trials in Hospital del Mar; Servicio de Oncologia,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital del Mar; Servicio de Oncologia, 13 "Phase 1"
clinical trials were conducted, 15 "Phase 2" clinical
trials and 19 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".